Ex-Hunton Patent Atty Convicted Of Insider Trading

Law360, New York (March 15, 2017, 2:13 PM EDT) -- A former Hunton & Williams LLP patent attorney on Wednesday was convicted by a Brooklyn federal jury of insider trading charges for tipping off his friend and investment adviser about Pfizer Inc.'s plans to acquire his drugmaker client.

Former Hunton & Williams patent attorney Robert Schulman was accused of telling investment adviser Tibor Klein that his client King Pharmaceuticals was going to merge with Pfizer. (AP) The jury deliberated for about five hours before finding Robert Schulman, 58, guilty of conspiracy and securities fraud following a...
To view the full article, register now.

Related

Sections

Case Information

Case Title

USA v. Klein et al


Case Number

2:16-cr-00442

Court

New York Eastern

Nature of Suit

Date Filed

August 4, 2016

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.